Transgene-design
Transgene-design designs mammalian transgenes by optimizing exonic synonymous-site GC content and modulating exonic splice enhancer (ESE) density to improve expression of human intronless transgenes and native retrogenes.
Key Features:
- GC optimization: Optimizes GC content at exonic synonymous sites to increase expression efficiency of human intronless transgenes and native retrogenes.
- ESE manipulation: Identifies and adjusts exonic splice enhancers (ESEs), allowing modulation of ESE density for intronless versus intron-containing contexts.
- Input flexibility: Accepts native gene sequences or commercially optimized sequences as input for redesign.
- First intron retention: Provides an option to retain the first intron within the gene sequence.
- Motif protection and avoidance: Allows protection or avoidance of specified sequence motifs that may influence gene expression or stability.
Scientific Applications:
- Gene expression regulation: Designs transgenes for experiments investigating determinants of mammalian gene expression.
- Functional genomics: Enables construction of transgenes for functional genomics assays in mammalian systems.
- Genetic engineering: Supports generation of optimized constructs for genetic engineering in mammalian cells.
- Therapeutic development: Facilitates design of transgenes relevant to development of novel therapeutic strategies.
Methodology:
Optimizes exonic synonymous-site GC content, identifies and adjusts exonic splice enhancers (ESEs), offers first intron retention, protects or avoids specified motifs, and accepts native or commercially optimized input sequences.
Topics
Details
- License:
- GPL-3.0
- Cost:
- Free of charge
- Tool Type:
- web application
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- Ruby
- Added:
- 6/28/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Mühlhausen S, Hurst LD. Transgene-design: a web application for the design of mammalian transgenes. Bioinformatics. 2022;38(9):2626-2627. doi:10.1093/bioinformatics/btac139. PMID:35244144. PMCID:PMC9048660.
PMID: 35244144
PMCID: PMC9048660
Funding: - European Research Council grant EvoGenMed: ERC-2014-ADG 669207
Links
Repository
https://github.com/smuehlh/transgenes